
Recently, the winners of the FBIF Wow Food Awards 2026 were officially announced. Bloomage’s FIXFLY™ Dual-A Combination — featuring UltraHA®J sodium hyaluronate for joint health and ACTIVENAG® N-acetylglucosamine — stood out among entries from around the world thanks to its breakthrough ingredient innovation and strong scientific foundation in the field of joint health. The combination was honored with the “Best Ingredient Innovation Award,” redefining new standards for joint health management through cutting-edge biotechnology.
Widely regarded as the “Oscars of China’s food industry,” the FBIF Wow Food Awards is a global and comprehensive award platform dedicated to innovation in the food and beverage industry. The 2026 awards featured four major categories: Product, Packaging, Marketing, and Ingredients. Since its launch in 2017, the awards have remained committed to discovering, recognizing, and showcasing outstanding innovations across the food and beverage sector, attracting participation from more than 3,000 teams, over 5,000 submissions, and 300+ industry expert judges worldwide. This recognition represents strong industry acknowledgement of Bloomage’s innovation capabilities and scientific expertise.

FIXFLY™ Dual-A Combination:Science-Backed Innovation for Comprehensive Joint Health Support
As a synthetic biology-driven biotechnology company, Bloomage was among the first to achieve large-scale biosynthesis of hyaluronic acid — a key anti-aging bioactive substance — and has maintained the world’s leading market share for years. Building on this foundation, the company has expanded into frontier research in glycobiology and cell biology. Leveraging its globally leading synthetic biology and biomanufacturing platform, Bloomage is committed to translating life science breakthroughs into innovative solutions for aging intervention, tissue regeneration, and other health-related applications.
The award-winning FIXFLY™ Dual-A Combination reflects Bloomage’s focus on addressing common joint health challenges. Built upon two core ingredients — UltraHA®J sodium hyaluronate for joint applications and ACTIVENAG® N-acetylglucosamine — the solution was developed through dual research dimensions of “synergistic efficacy” and “combined absorption,” delivering a scientific and highly effective approach to joint care.

Unlike traditional single-ingredient solutions, the FIXFLY™ Dual-A Combination precisely targets key joint health needs:
- UltraHA®J specifically replenishes hyaluronic acid in synovial fluid, providing cushioning, shock absorption, and long-lasting joint lubrication;
- ACTIVENAG®, as a key structural component of cartilage, supports cartilage matrix synthesis, helps repair damaged cartilage, and stabilizes joint structure.
Through the scientific combination of these two active ingredients, the combination achieves a synergistic effect greater than the sum of its parts, establishing a multidimensional protection system integrating joint lubrication, cartilage repair, soothing support, and anti-inflammatory benefits for more comprehensive and efficient joint health management.

To validate the efficacy of the FIXFLY™ Dual-A Combination, Bloomage conducted rigorous animal studies. Osteoarthritis-like pathological conditions were induced in rats through intra-articular injection of sodium iodoacetate. The study included a control group, a model group, multiple ACTIVENAG® dosage groups, and a Dual-A Combination group.
Results from the four-week intervention demonstrated that the Dual-A Combination significantly outperformed ACTIVENAG® alone. The combination effectively reduced joint swelling, suppressed inflammatory responses, maintained cartilage protein levels, and reduced degradation of cartilage components, delivering multidimensional improvements in joint health and providing strong scientific support for its functional efficacy.
Research-Driven Innovation Leading the Future of Functional Foods
From laboratory breakthroughs to recognition by a prestigious industry award, the success of the FIXFLY™ Dual-A Combination represents both Bloomage’s innovation strength in joint health and its broader commitment to advancing industry transformation through scientific research.
Looking ahead, Bloomage will continue exploring the application potential of bioactive substances and developing more efficient and safe health solutions to support better joint health for consumers while driving the high-quality development of the functional food industry.